Lecanemab is the first treatment for Alzheimer’s disease licensed for use in Great Britain that shows some evidence of ...

A groundbreaking medication designed to delay the onset of Alzheimer's has received approval for use within the EU. The drug, ...

Onconova Therapeutics Inc ( (TRAW) ) has released its Q3 earnings. Here is a breakdown of the information Onconova Therapeutics Inc presented ...

Doctors recommend avoiding NSAIDs after a flu vaccination because these can dampen the immune response by slashing the ...

This marks the state’s first human case of bird flu. The Oregon Health Authority said the case is linked to an outbreak in ...

Eyenovia said on Friday it will discontinue a late-stage study for its experimental drug-device combination to treat near-sightedness and cut about 50% of its workforce.

The Lice Treatment Global Market Report 2024 from ResearchAndMarkets.com reveals that there has been a 'global rise in the ...

The prescribing of antiviral drugs for US children and adolescents receiving treatment for influenza was less than 60% in the ...

Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

A 911 hang-up call leads police to a North Bay hotel room resulting in the seizure of $130,000 in drugs and one man being ...

Explore the implications of Robert F. Kennedy Jr.'s controversial nomination by Donald Trump as Health Czar and Secretary of ...